Lab Research
Unrestrained MyD88 Signaling in A20-Deficient Keratinocytes Triggers T-Cell-Dependent Psoriatic Arthritis-Like Disease.
Tobias R, Kumar S, Liu J, Lenci N, Gharabi A, Stibor D, Advincula R, Achacoso P, Huang ZM, Bowman C, Ricardo-Gonzalez R, Nakamura MC, Liao W, Malynn BA, Ma A, Razani B.
J Invest Dermatol. 2025
Non-catalytic ubiquitin binding by A20 prevents psoriatic arthritis-like disease and inflammation.
Razani B, Whang MI, Kim FS, Nakamura MC, Sun X, Advincula R, Turnbaugh JA, Pendse M, Tanbun P, Achacoso P, Turnbaugh PJ, Malynn BA, Ma A.
Nat Immunol. 2020
Collaborative Research
A20’s Linear Ubiquitin Binding Motif Restrains Pathogenic Activation of TH17/22 cells and IL-22 Driven Enteritis
Bowman CJ, Stibor DM, Sun X, Lenci N, Shimizu H, Yamashita EF, Advincula R, Kim MC, Turnbaugh JA, Sun Y, Razani B, Turnbaugh PJ, Ye CJ, Malynn BA, Ma A. A20's linear ubiquitin-binding motif restrains pathogenic activation of Th17 cells and IL-22-driven enteritis.
J Clin Invest. 2025
Microbial signals, MyD88, and lymphotoxin drive TNF-independent intestinal epithelial tissue damage.
Rusu I, Mennillo E, Bain JL, Li Z, Sun X, Ly KM, Rosli YY, Naser M, Wang Z, Advincula R, Achacoso P, Shao L, Razani B, Klein OD, Marson A, Turnbaugh JA, Turnbaugh PJ, Malynn BA, Ma A, Kattah MG.
J Clin Invest. 2022
Reviews and Perspectives
A New Mouse Model of Psoriatic Arthritis.
Razani B, Chandran V, de Vlam K, Liao W, Malynn BA, Ma A.
J Rheumatol. 2025
Preserving immune homeostasis with A20.
Razani B, Malynn BA, Ma A.
Adv Immunol. 2020